Vuddhidej Ophascharoensuk

Vuddhidej Ophascharoensuk

Auto-generated profile, based on publicly available information

Vuddhidej Ophascharoensuk

Division of Nephrology, Department of Medicine, Faculty of Medicine Chiang Mai University Chiang Mai Thailand

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2021 in Asia Pacific Journal of Public Health
Verified
Journal Article
Closed access
PDF file
PCPairoj Chattranukulchai
Pairoj Chattranukulchai
NTNuntakorn Thongtang
Nuntakorn Thongtang
VOVuddhidej Ophascharoensuk
Vuddhidej Ophascharoensuk
SMSombat Muengtaweepongsa
Sombat Muengtaweepongsa
CAChaisiri Angkurawaranon
Chaisiri Angkurawaranon
ASApichard Sukonthasarn
Apichard Sukonthasarn
To maintain the continuity of noncommunicable disease (NCD) services and ascertain the health outcomes of patients with NCDs during the COVID-19 (coronavirus disease 2019) outbreak in Thailand, various telemedicine services have been developed. To achieve this determination, the implementation framework has been constructed based on recommendations from multidisciplinary experts (Thai NCD Collaboration Group). Within the framework, all key elements are illustrated with their priority and expected collaborations. Ultimately, active collaborations from multi-stakeholders are vitally important to ensure that telemedicine services for NCDs will finally become practical, successful, and sustainable.

3 August 2023 in Nephrology
Verified
Journal Article
Closed access
GHGuttiga Halue
Guttiga Halue
HTHuttaporn Tharapanich
Huttaporn Tharapanich
JPJeerath Phannajit
Jeerath Phannajit
TKTALERNGSAK KANJANABUCH
TALERNGSAK KANJANABUCH
ABAthiphat Banjongjit
Athiphat Banjongjit
TCThailand PDOPPS Steering Committee
Thailand PDOPPS Steering Committee

16 June 2025 in Therapeutic Apheresis and Dialysis
Verified
Journal Article
Closed access
BSBancha Satirapoj
Bancha Satirapoj
PTPichaya Tantiyavarong
Pichaya Tantiyavarong
PTParamat Thimachai
Paramat Thimachai
ACAnan Chuasuwan
Anan Chuasuwan
ALAdisorn Lumpaopong
Adisorn Lumpaopong
VOVuddhidej Ophascharoensuk
Vuddhidej Ophascharoensuk

3 August 2023 in Nephrology
Verified
Journal Article
Closed access
TKTALERNGSAK KANJANABUCH
TALERNGSAK KANJANABUCH
SISuramath Isaranuwatchai
Suramath Isaranuwatchai
TNTanawin Nopsopon
Tanawin Nopsopon
TTTheerachai Thammathiwat
Theerachai Thammathiwat
TPThitipong Pooprasert
Thitipong Pooprasert
TTThe Nephrology Society Of Thailand
The Nephrology Society Of Thailand

25 April 2026 in Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
Verified
Journal Article
Closed access
SBSarinya Boongird
Sarinya Boongird
TKTALERNGSAK KANJANABUCH
TALERNGSAK KANJANABUCH
JPJeerath Phannajit
Jeerath Phannajit
PCPiyatida Chuengsaman
Piyatida Chuengsaman
JTJadej Thammatacharee
Jadej Thammatacharee
VOVuddhidej Ophascharoensuk
Vuddhidej Ophascharoensuk
Thailand's peritoneal dialysis (PD) policy evolution illustrates how apparent policy success can mask underlying system vulnerabilities. Between 2008 and 2021, Thailand's PD-First policy under the Universal Coverage Scheme (UCS) became an international model, expanding PD utilization from 2760 to over 25,000 patients while maintaining outcomes comparable to global benchmarks. In February 2022, the 2022 Policy removed PD-First restrictions to enhance patient choice. Within 3 years, PD utilization among incident UCS patients declined from 50% to 14%, 90-day mortality risk rose from 9% to 13%, and dialysis expenditures increased to 12% of the total UCS budget. These outcomes prompted the 2025 Reform in April 2025, following a review commissioned by the National Health Security Office and conducted by the Health Intervention and Technology Assessment Program (HITAP), with expert input from the Nephrology Society of Thailand (NST) and other stakeholders. Using aggregated national registry data across three periods—the PD-First period (2008–2021), the 2022 Policy period (2022–2024), and the 2025 Reform period (2025)—we examined utilization patterns, clinical outcomes, and fiscal impacts associated with these transitions. The temporal patterns suggest that rapid policy liberalization may expose and amplify existing capacity imbalances. Following the 2022 transition, utilization shifted toward existing hemodialysis infrastructure despite inadequate vascular surgery capacity, coinciding with reduced rates of permanent access and increased early mortality. Preliminary post-reform data show encouraging recovery, with 90-day mortality risk falling to 7%. Thailand's experience may inform countries expanding home dialysis through policy reforms, highlighting that sustainable choice requires sequenced policy liberalization, infrastructure capacity alignment, and responsive governance to maintain dialysis quality, equity, and fiscal stability.